JCO Precision Oncology

Published by: American Society of Clinical Oncology  

People

  1. Kris
    Kris
  2. Arcila
    Arcila
  3. Drilon
    Drilon
  4. Riely
    Riely
  5. Ladanyi
    Ladanyi
  6. Rekhtman
    Rekhtman
  7. Rudin
    Rudin
  8. Chang
    Chang
  9. Guo
    Guo
  10. Offin
    Offin

Groups

  1. Department of Medicine (9)
  2. Solid Tumor Oncology Division (9)
  3. Thoracic Oncology (9)
  4. Department of Pathology and Laboratory Medicine (7)
  5. Weinberg Fellows (6)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  7. Center for Molecular Imaging and Biotechnology (CMIB) (4)
  8. GSK Faculty (4)
  9. Hematology-Oncology Fellows (4)
  10. Human Oncology and Pathogenesis Program (4)
Search Within
  1. "Mark Kris"
Formats
  1. Journal Article (9)
Groups
  1. Department of Medicine (9)
  2. Solid Tumor Oncology Division (9)
  3. Thoracic Oncology (9)
  4. Department of Pathology and Laboratory Medicine (7)
  5. Weinberg Fellows (6)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)

More Groups

People
  1. Mark Kris (9)
  2. Alexander Drilon (5)
  3. Gregory Riely (5)
  4. Maria Arcila (5)
  5. Charles Rudin (4)
  6. Marc Ladanyi (4)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (3)
  6. 2018 (1)
Publishers
  1. American Society of Clinical Oncology (9)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes after radiation for oligoprogressive disease sites in patients with EGFR-mutant lung cancer treated with osimertinib
    Journal Article

    Chen, M. F.; Jeng, M. Y.; Ma, J.; Agrawal, P.; Dunne, E.; Boe, L. A.; Kris, M. G.; Huang, J.; Veeraraghavan, H.; Gomez, D.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Response to repotrectinib after development of NTRK resistance mutations on first- and second-generation TRK inhibitors
    Journal Article

    Chen, M. F.; Yang, S. R.; Shia, J.; Girshman, J.; Punn, S.; Wilhelm, C.; Kris, M. G.; Cocco, E.; Drilon, A.; Raj, N.
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Erlotinib and trametinib in patients with EGFR-mutant lung adenocarcinoma and acquired resistance to a prior tyrosine kinase inhibitor
    Journal Article

    Luo, J.; Makhnin, A.; Tobi, Y.; Ahn, L.; Hayes, S. A.; Iqbal, A.; Ng, K.; Arcila, M. E.; Riely, G. J.; Kris, M. G.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Randomized phase II study of 3 months or 2 years of adjuvant afatinib in patients with surgically resected stage I-III EGFR-mutant non-small-cell lung cancer
    Journal Article

    Neal, J. W.; Costa, D. B.; Muzikansky, A.; Shrager, J. B.; Lanuti, M.; Huang, J.; Ramachandran, K. J.; Rangachari, D.; Huberman, M. S.; Piotrowska, Z.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • CNS metastases in patients with MET exon 14-altered lung cancers and outcomes with crizotinib
    Journal Article

    Offin, M.; Luo, J.; Guo, R.; Lyo, J. K.; Falcon, C.; Dienstag, J.; Wilkins, O.; Chang, J.; Rudin, C. M.; Riely, G.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Response to selective RET inhibition with LOXO-292 in a patient with RET fusion-positive lung cancer with leptomeningeal metastases
    Journal Article

    Guo, R.; Schreyer, M.; Chang, J. C.; Rothenberg, S. M.; Henry, D.; Cotzia, P.; Kris, M. G.; Rekhtman, N.; Young, R. J.; Hyman, D. M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Immunophenotype and response to immunotherapy of RET-rearranged lung cancers
    Journal Article

    Offin, M.; Guo, R.; Wu, S. L.; Sabari, J.; Land, J. D.; Ni, A.; Montecalvo, J.; Halpenny, D. F.; Buie, L. W.; Pak, T.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Harnessing clinical sequencing data for survival stratification of patients with metastatic lung adenocarcinomas
    Journal Article

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M.; Arbour, K. C.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Acquired ALK and RET gene fusions as mechanisms of resistance to osimertinib in EGFR-mutant lung cancers
    Journal Article

    Offin, M.; Somwar, R.; Rekhtman, N.; Benayed, R.; Chang, J. C.; Plodkowski, A.; Lui, A. J. W.; Eng, J.; Rosenblum, M.; Li, B. T.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save

    • JCO Precision Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 Unknown
    Jco Precision Oncology Lippincott Williams & Wilkins
    Jco Precision Oncology American Society of Clinical Oncology
    Jco Precision Oncology American Society of Clinical Oncology
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    Unknown (24734284) 24734284 American Society of Clinical Oncology